Show simple item record

dc.contributor.authorWei, X. N.
dc.contributor.authorHan, B. C.
dc.contributor.authorZhang, J. X.
dc.contributor.authorLiu, X. H.
dc.contributor.authorTan, C. Y.
dc.contributor.authorJiang, Y. Y.
dc.contributor.authorLow, Boon Chuan
dc.contributor.authorTidor, Bruce
dc.contributor.authorChen, Yu Zong
dc.date.accessioned2011-09-21T17:34:56Z
dc.date.available2011-09-21T17:34:56Z
dc.date.issued2011-07
dc.date.submitted2011-02
dc.identifier.issn1752-0509
dc.identifier.urihttp://hdl.handle.net/1721.1/65907
dc.description.abstractBackground: Endothelial permeability is involved in injury, inflammation, diabetes and cancer. It is partly regulated by the thrombin-, histamine-, and VEGF-mediated myosin-light-chain (MLC) activation pathways. While these pathways have been investigated, questions such as temporal effects and the dynamics of multi-mediator regulation remain to be fully studied. Mathematical modeling of these pathways facilitates such studies. Based on the published ordinary differential equation models of the pathway components, we developed an integrated model of thrombin-, histamine-, and VEGF-mediated MLC activation pathways. Results: Our model was validated against experimental data for calcium release and thrombin-, histamine-, and VEGF-mediated MLC activation. The simulated effects of PAR-1, Rho GTPase, ROCK, VEGF and VEGFR2 over-expression on MLC activation, and the collective modulation by thrombin and histamine are consistent with experimental findings. Our model was used to predict enhanced MLC activation by CPI-17 over-expression and by synergistic action of thrombin and VEGF at low mediator levels. These may have impact in endothelial permeability and metastasis in cancer patients with blood coagulation. Conclusion: Our model was validated against a number of experimental findings and the observed synergistic effects of low concentrations of thrombin and histamine in mediating the activation of MLC. It can be used to predict the effects of altered pathway components, collective actions of multiple mediators and the potential impact to various diseases. Similar to the published models of other pathways, our model can potentially be used to identify important disease genes through sensitivity analysis of signalling components.en_US
dc.description.sponsorshipSingapore-MIT Allianceen_US
dc.description.sponsorshipNational University of Singapore (grant 2007AA02Z160)en_US
dc.description.sponsorshipNational University of Singapore (grant 2009ZX09501-004)en_US
dc.description.sponsorshipNational Natural Science Foundation (China)en_US
dc.description.sponsorshipSingapore-MIT Alliance for Research and Technology Centeren_US
dc.description.sponsorshipSingapore. Ministry of Science and Technologyen_US
dc.description.sponsorshipKey Special Project Grant 2009ZX09501-00 of Chinaen_US
dc.publisherBioMed Central Ltden_US
dc.relation.isversionofhttp://dx.doi.org/10.1186/1752-0509-5-112en_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.0en_US
dc.sourceBioMed Central Ltden_US
dc.titleAn Integrated Mathematical Model of Thrombin-, Histamine-and VEGF-Mediated Signalling in Endothelial Permeabilityen_US
dc.typeArticleen_US
dc.identifier.citationBMC Systems Biology. 2011 Jul 15;5(1):112en_US
dc.contributor.departmentMassachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratoryen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Electrical Engineering and Computer Scienceen_US
dc.contributor.approverTidor, Bruce
dc.contributor.mitauthorTidor, Bruce
dc.contributor.mitauthorLow, Boon Chuan
dc.relation.journalBMC Systems Biologyen_US
dc.eprint.versionFinal published versionen_US
dc.identifier.pmid21756365
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2011-08-02T15:05:09Z
dc.language.rfc3066en
dc.rights.holderWei et al.; licensee BioMed Central Ltd.
dspace.orderedauthorsWei, XN; Han, BC; Zhang, JX; Liu, XH; Tan, CY; Jiang, YY; Low, BC; Tidor, B; Chen, YZen
dc.identifier.orcidhttps://orcid.org/0000-0002-3320-3969
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record